Skip to content

Control of Signs & Recurrence of Nephritic Syndrome

The Effect of Continuous Care Model On Control of Signs & Recurrence Among The Children With Nephritic Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012070810209N1
Enrollment
66
Registered
2013-03-05
Start date
2012-07-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nephrotic Syndrome. Isolated proteinuria with specified morphological lesion

Interventions

Intervention 1: Case group : After collecting basic data, a questionnaire on demographic characteristics and also measuring blood pressure, Triglyceride and Cholesterol, weight and urine tests , con
Case group : After collecting basic data, a questionnaire on demographic characteristics and also measuring blood pressure, Triglyceride and Cholesterol, weight and urine tests , continuous care mo
Control group : In this study after collecting demographic data and measuring of body weight, blood pressure, triglyceride and cholesterol and record of recurrence, Continuous Care Model won't be

Sponsors

Ahvaz Jundishapur University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1- Passing at least 3 months from nephritic syndrome onset in the children 2- Not to be affected child and his or her parents to the problems such as mental retardation, mental illness... 3- The consent of child and his or her parents to participate in this study Exclusion criteria: 1- If during the study, sensitive and dependent nephritic syndrome disease in the patient changes to resistant nephritic syndrome 2-If patient and his or her parents are affected by any physical disease associated with nephritic syndrome during the study 3- If patient and his or her parents participate only in two educational sessions

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
TG,Chol. Timepoint: before & after study. Method of measurement: A blood test & check the lipid.;Proteinuria. Timepoint: during and after the study. Method of measurement: A urin test & check the Proteinuria.;Body weight. Timepoint: before & after study. Method of measurement: Using analog scale SECA mark.;Blood presure. Timepoint: before & after study. Method of measurement: Using a pressure gauge ALPK2 model.;Knowledge. Timepoint: before & after study. Method of measurement: questionnaire regarding the knowledge rate of parents about symptoms of the nephrotic syndrome disease recurrence.;Recurence and control of signs of nephrotic syndrom. Timepoint: Before the intervention, and three months after intervention. Method of measurement: Bp measured by a counterclockwise pressure cuff on Mark ALPK2 on mmHg,BW measured byBranded analogue scales SECA, Measurement of lipid per dl / mg,Urine test for the presence of protein in the urine using reagent strips in scale, 0 to + + + + partial,To measure the reliability and validity of a questionnaire to assess knowledge has been approved by the Faculty of Medical Sciences.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAshraf Al Sadat Hakim

Ahvaz Jundishapur University of Medical Sciences

Hakim3448200@yahoo.comhakim-a@ajums.ac.ir+98 61 1373 8261

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026